Outcomes of combination therapy with nusinersen, onasemnogene abeparvovec, and risdiplam over 3.5 years in a patient with prenatally diagnosed spinal muscular atrophy type 0: A case report
Brain and Development · 2026
DOI: 10.1016/j.braindev.2026.104520 ↗Kurz gefasst
Fallbericht in der Zeitschrift Brain and Development, 2026. Verfasst von Yukimune Okubo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, Miyagi Children Hospital, Sendai, Japan. Electronic address: yokubom@yahoo.co.jp. Hauptthemen laut MEDLINE: Spinal Muscular Atrophies of Childhood, Oligonucleotides, Recombinant Fusion Proteins, Pyrimidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Neurology, Miyagi Children Hospital, Sendai, Japan. Electronic address: yokubom@yahoo.co.jp.
- Department of Pediatric Neurology, Miyagi Children Hospital, Sendai, Japan.
- Department of Rehabilitation and Developmental Support, Miyagi Children's Hospital, Sendai, Japan.
- Department of Physiological Examination, Miyagi Children's Hospital, Sendai, Japan.
- Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
- Department of Pediatric Neurology, Miyagi Children Hospital, Sendai, Japan. Electronic address: khaginoya@kha.biglobe.ne.jp.
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Okubo, Y., Togashi, N., Morishita, Y., Yoshida, S., Kawaji, T., Kawashima, A., Katata, Y., Uneoka, S., Yagi, Y., Endo, W., Inui, T., Kato, T., Yokomura, M., Otsuki, N., Saito, K., & Haginoya, K. (2026). Outcomes of combination therapy with nusinersen, onasemnogene abeparvovec, and risdiplam over 3.5 years in a patient with prenatally diagnosed spinal muscular atrophy type 0: A case report. Brain and Development. https://doi.org/10.1016/j.braindev.2026.104520
Vancouver
Okubo Y, Togashi N, Morishita Y, Yoshida S, Kawaji T, Kawashima A, et al. Outcomes of combination therapy with nusinersen, onasemnogene abeparvovec, and risdiplam over 3.5 years in a patient with prenatally diagnosed spinal muscular atrophy type 0: A case report. Brain and Development. 2026. doi:10.1016/j.braindev.2026.104520
BibTeX
@article{Okubo2026,
author = {Okubo, Yukimune and Togashi, Noriko and Morishita, Yuko and Yoshida, Sayaka and Kawaji, Takahiro and Kawashima, Aritomo and Katata, Yu and Uneoka, Saki and Yagi, Yuki and Endo, Wakaba and Inui, Takehiko and Kato, Tamaki and Yokomura, Mamoru and Otsuki, Noriko and Saito, Kayoko and Haginoya, Kazuhiro},
title = {Outcomes of combination therapy with nusinersen, onasemnogene abeparvovec, and risdiplam over 3.5 years in a patient with prenatally diagnosed spinal muscular atrophy type 0: A case report},
journal = {Brain and Development},
year = {2026},
doi = {10.1016/j.braindev.2026.104520}
}
EUVIMED